Abstract
Aggregation or reversible self-association of protein therapeutics can arise through a number of different mechanisms. Five common aggregation mechanisms are described and their relations to manufacturing processes to suppress and remove aggregates are discussed.
MeSH terms
-
Biopharmaceutics / methods*
-
Chemical Fractionation / methods*
-
Models, Chemical
-
Multiprotein Complexes / chemistry*
-
Multiprotein Complexes / isolation & purification*
-
Proteins / chemistry*
-
Proteins / isolation & purification*
-
Technology, Pharmaceutical / methods*
Substances
-
Multiprotein Complexes
-
Proteins